Page last updated: 2024-10-29

iohexol and Leukocytosis

iohexol has been researched along with Leukocytosis in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Leukocytosis: A transient increase in the number of leukocytes in a body fluid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robert, C1
Gandon, Y1
Peyronnet, B1
Gauthier, S1
Aubé, C1
Paisant, A1
Vollmann, R1
Schaffler, GJ1
Spreizer, C1
Quehenberger, F1
Schoellnast, H1

Other Studies

2 other studies available for iohexol and Leukocytosis

ArticleYear
Utility of enhanced CT for patients with suspected uncomplicated renal colic and no acute findings on non-enhanced CT.
    Clinical radiology, 2019, Volume: 74, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Creatinine; Emergency Service, Hospital;

2019
Clinical significance of periportal tracking as an extrarenal manifestation of acute pyelonephritis.
    Abdominal imaging, 2011, Volume: 36, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Contrast Media; Femal

2011